Clinical trial Recruiting at 1 site Interventional Ages 18 to 50

tACS to help tell self from others in schizophrenia

Official title: Transcranial Alternating Current Stimulation (tACS) at 10 Hz Targeting Medial Prefrontal Cortex for Improving Self-Other Differentiation in Patients With Schizophrenia: A Randomized, Double-Blind, Sham-Controlled Trial

Run by Anhui Medical University · NCT07818668 · Data updated 2026-11-12

A non-invasive brain stimulation method (tACS) is tested to see if it helps people with schizophrenia better distinguish themselves from others.

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexAll
Enrollment100 (estimated)
SponsorAnhui Medical University
Academic / other
Locations1 site (Hefei, Anhui)
StatusRecruiting
StartedMarch 17, 2026
Main results expectedSeptember 15, 2027
Study endsSeptember 30, 2027
Registry record updatedSeptember 17, 2026
Trial IDNCT07818668 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18-50 with a DSM-5 diagnosis of schizophrenia and current hallucinations or delusions, medically stable on antipsychotic meds for at least 4 weeks.

Probably not a fit

Individuals without schizophrenia or those not meeting stability criteria may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study uses transcranial alternating current stimulation (tACS) targeting the medial prefrontal cortex to see if it improves self-other boundary processing in schizophrenia. Participants include patients with schizophrenia, people with high schizotypal traits, and healthy controls, to explore underlying mechanisms through behavioral tasks and brain activity. The protocol involves 10 Hz stimulation at 2 mA for 20 minutes daily over five days, with a sham control for comparison. Two computer-based face-recognition tasks manipulate prior probability and perceptual uncertainty to probe self-other processing.

Why it matters

Potential benefit: If successful, this approach could improve social cognition and self-awareness in schizophrenia.

How similar studies have gone: Similar non-invasive brain stimulation approaches have shown mixed results; this study explores a targeted mechanism with a novel design.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of schizophrenia according to DSM-5 criteria
* Presence of hallucinations or delusions
* Age between 18 and 50 years
* Clinically stable on a stable dose of antipsychotic medication for at least 4 weeks prior to enrollment, with no anticipated medication changes during the study period
* Normal or corrected-to-normal vision (≥ 20/40) as assessed by standard visual acuity test
* Able to understand and provide written informed consent

Exclusion Criteria:

* History of neurological disorders (e.g., epilepsy, stroke, traumatic brain injury)
* Presence of other major psychiatric disorders (e.g., bipolar disorder, major depressive disorder)
* Previous receipt of non-invasive brain stimulation (e.g., tACS, tDCS, rTMS)
* History of substance dependence or abuse within the past 6 months
* Metal implants in the head or skull (e.g., cochlear implants, deep brain stimulators)
* Pregnancy or breastfeeding
* Presence of skin lesions, wounds, or sensitive skin at electrode placement sites (Fpz, AF7, AF8, F5, F6)

Where it's running

  • The Fourth People's Hospital of Hefei
    Hefei, Anhui, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.